 The AbioCor won FDA approval in 2006 for patients who are near death and do not qualify for a heart transplant.In 2004, Michael R. Minogue became president and CEO of Abiomed.In 2005, Abiomed purchased ventricular assist device company Impella CardioSystems AG of Aachen, Germany, maker of the Impella heart pump, developed by Thorsten Siess, who is now the Chief Technology Officer at Abiomed.